Surgery – Means for introducing or removing material from body for... – Material introduced into and removed from body through...
Patent
1995-07-14
1999-08-03
Stright, Jr., Ronald K.
Surgery
Means for introducing or removing material from body for...
Material introduced into and removed from body through...
604 51, 6048901, 424450, 424457, 128898, A61M 3100
Patent
active
059318090
ABSTRACT:
A drug delivery system provides sustained-release delivery of therapeutic biologically active compounds administered epidurally. In the preferred embodiment the biologically active compound is an opioid, which is encapsulated within the non-concentric internal aqueous chambers or bilayers of multivesicular liposomes. The opioid is released over an extended period of time when the liposomes are introduced epidurally as a single dose for sustained analgesia.
REFERENCES:
patent: Re35192 (1996-03-01), Reese
patent: 4078052 (1978-03-01), Papahadjopoulos
patent: 4089801 (1978-05-01), Schneider
patent: 4145410 (1979-03-01), Sears
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4310506 (1982-01-01), Baldeschwieler et al.
patent: 4394372 (1983-07-01), Taylor
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4752425 (1988-06-01), Martin et al.
patent: 4769250 (1988-09-01), Forssen
patent: 4781871 (1988-11-01), West, III et al.
patent: 4920016 (1990-04-01), Allen et al.
patent: 4921853 (1990-05-01), LeBlanc
patent: 5000959 (1991-03-01), Iga et al.
patent: 5021200 (1991-06-01), Vanlerberghe et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5091187 (1992-02-01), Hayes
patent: 5204112 (1993-04-01), Hope et al.
patent: 5211955 (1993-05-01), Legros et al.
patent: 5227165 (1993-07-01), Domb et al.
patent: 5244678 (1993-09-01), Legros et al.
patent: 5246707 (1993-09-01), Haynes
patent: 5261903 (1993-11-01), Dhaliwal et al.
patent: 5451408 (1995-09-01), Mezei et al.
Studies on Phosphatidylcholine Vesicles Formation and Physical Characteristics Huang, Biochemistry, 8:334-352, 1969.
Diffusion of Univalent Ions Across The Lamellae of Swollen Phospholipids Bangham, J. Mol. Bio., 13:238-252, 1965.
Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes) Szoka, et al., Ann. Rev. Biophys. Bioengineering, 9:467-508, 1980.
Evaluation of Retinal Toxicity and Liposome Encapsulation of the Anti-CMV Drug 2'-nor-cyclic GMP Shakiba, et al., Investigative Ophthalmology and Visual Science, No. 10, 34:2903-2910, Sep. 1993.
Fibrin-Enmeshed Tobramycin Liposomes: Single Application Topical Therapy of . . . Frucht-Perry, et al., Cornea, No. 5, 11:393-397, Sep. 1992.
Tobramycin Liposomes. Single Subconjunctival Therapy of . . . Assil, et al., Investigative Ophthalmology and Visual Science, No. 13, 32:3216-3220, Dec. 1991.
Liposome Suppression of Proliferative Vitreoretinopathy. Rabbit . . . Assil, et al., Investigative Ophthalmology and Visual Science, No. 11, 32:2891-2897, Oct. 1991.
Magnetic Resonance Imaging of Rabbit Brain After Intracarotid Injection . . . Turski, et al., Magnetic Resonance in Medicine, No. 2, 7:184-196, Jun. 1988.
Filtering Surgery in Owl Monkeys Treated With the Antimetabolite . . . Skuta, et al., American Journal of Ophthalmology, No. 5, 103:714-716, May 15, 1987.
Multivesicular Liposomes. Sustained Release of the Antimetabolite . . . Assil, et al., Archives of Ophthalmology, No. 3, 105:400-403, Mar. 1987.
Weak Acid-Induced Release of Liposome-Encapsulated Carboxyfluorescein Barbet, et al., Biochimica et Biophysica Acta, No. 3, 772:347-356, May 30, 1984.
Preparation of Cell-Size Unilamellar Liposomes with High Captured Volume and Defined Size . . . Kim, et al., Biochim. Biophys. Acta, 646:1-9, 1981.
Preparation of Multivesicular Lipsomes Kim, et al., Biochim. Biophys. Acta, 728:339-348, 1983.
Preparation of Multilamellar Vesicles of Defined Size-Distribution by Solvent-Spherule . . . Kim, et al., Biochim. Biophys. Acta, 812:793-801, 1985.
Multivesicular Liposomes Containing Cytarabine Entrapped in the Presence of . . . Kim, et al., Cancer Treat. Rep., 71:705-711, 1987.
Multivesicular Liposomes Containing Cytosine 1-.beta.-D-Arabinofuranosylcytosine for Slow-Release Intrathecal Therapy Kim, et al., Cancer Research, 47:3935-3937, 1987.
Multivesicular Liposomes Containing Cytosine for Slow Release . . . Kim, et al., Cancer Treat Rep., 71:447-450, 1987.
Modulation of the Peritoneal Clearance of Liposomal Cytosine Arabinoside by . . . Kim, et al., Cancer Chemother. Pharmacology, 19:307-310, 1987.
Multivesicular Liposomes Containing Bleomycin for Subcutaneous Administration Roy, et al., Cancer Chemother. Pharmacology, 28:105-108, 1991.
Prolongation of Drug Exposure in Cerebrospinal Fluid by Encapsulation Into . . . Kim, et al. Cancer Research, 55:1596-1598, Apr. 1, 1993.
Direct Cerebrospinal Fluid Delivery of an Antiretroviral Agent Using . . . Kim, et al., Jrnl. of Infectious Diseases., 162:750-752, 1990.
Treatment of Leptomeningeal Metastasis with Intraventricular Administration of . . . Chamberlain, et al., Archives of Neurol, No. 3, 50:261-264, 1993.
A Slow-Release Methotrexate Formulation for Inrathecal Chemotherapy Chatelut, et al., Cancer Chemother. Pharmacol., 32:179-182, 1993.
Quantitative Cerebrospinal Fluid Cytology in Patients Receiving Intracavitary Chemotherapy Russack, et al., Ann. Neurol., 34:108-112, 1993.
Extended Cerebrospinal-Fluid Cytarabine Exposure Following Intrathecal Administration of DTC 101 Kim, et al., J. Clin. Oncol., 11:2186-2193, 1993.
Liposomes as Carriers of Cancer Chemotherapy: A Review Kim, Drugs, No. 4, 46:618-638, 1993.
Extended-Release Formulation of Morphine for Subcutaneous Administration Kim, et al., Cancer Chemother. Pharmacol., 33:187-190, 1993.
Production and Size Control of Large Unilamellar Liposomes by Emulsification Ishii, Liposome Technology, 1:111-121, 1993.
Structural Properties and Functional Roles of Phospholipids In . . . Cullis, et al., Phospholipids and Cellular Regulation, 1:65-123, 1985.
An Extended-Release Formulation of Methotrexate For Subcutaneous . . . Bonetti, et al., Cancer Chemotherapy and Pharmacology., In Press, 1994.
Novel Multilayered Lipid Vesicles: Comparison of Physical Characteristics of Multilamellar Liposomes and Stable Plurilamellar Vesicles Grunor, et al., Biochemistry, No. 12, 24:2833-2842, Jun. 4, 1985.
Gruber Andres
Kim Sinil
Kim Tae-hee
Murdande Sharad B.
DepoTech Corporation
Stright Jr. Ronald K.
LandOfFree
Epidural administration of therapeutic compounds with sustained does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epidural administration of therapeutic compounds with sustained , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epidural administration of therapeutic compounds with sustained will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-844300